Stem Cell Transplant Diagnosis and Evaluation

What Are Stem Cells? A Guide to Regenerative Medicine

Stem cells can develop into many cell types and act as the body’s repair system. They replace or restore damaged tissues, offering new possibilities for treating diseases.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

The Pre-Transplant Assessment Phase

The Pre-Transplant Assessment Phase

The journey toward a stem cell transplant begins with a comprehensive and exhaustive evaluation phase. This period is critical for establishing a baseline of the patient’s health, confirming the specific nature of the disease, and identifying the optimal donor strategy. The diagnostic process is multidisciplinary, involving hematologists, oncologists, cardiologists, pulmonologists, and infectious disease specialists. The goal is to stratify risk and ensure that the potential benefits of this intensive regenerative therapy outweigh the inherent dangers of toxicity and complications. At centers like Liv Hospital, this evaluation is streamlined into a cohesive pathway to expedite the time to transplant.

Icon LIV Hospital

Disease Status Verification

Disease Status Verification

Before a transplant can be scheduled, the precise status of the underlying disease must be confirmed. Stem cell transplants are most successful when the disease is in remission or at a low burden; performing a transplant on a patient with uncontrolled, bulky disease often leads to poor outcomes.

  • Bone Marrow Aspiration and Biopsy: This is the cornerstone diagnostic test for leukemias and marrow failure syndromes. Pathologists examine the marrow cellularity and look for residual blast cells (cancer cells).
  • Molecular and Cytogenetic Testing: Advanced genetic sequencing is performed to identify specific mutations (e.g., Philadelphia chromosome, FLT3) or chromosomal abnormalities. These markers serve as a “fingerprint” of the disease, allowing clinicians to track “minimal residual disease” (MRD) with high sensitivity. A negative MRD status before transplant is a strong predictor of long-term survival.
  • PET/CT and MRI Imaging: For lymphomas and multiple myeloma, functional imaging is used to map active disease sites throughout the body. These scans confirm whether the cancer has responded sufficiently to induction therapy to proceed with consolidation via transplant.
Icon 1 LIV Hospital

Physiological Organ Function Testing

Physiological Organ Function Testing

The conditioning regimens used in transplantation involve potent chemotherapy and sometimes radiation, which can place immense stress on vital organs. Therefore, a rigorous audit of organ function is mandatory.

  • Cardiac Evaluation: An echocardiogram or MUGA scan is performed to measure the left ventricular ejection fraction (LVEF). A strong heart is necessary to withstand the fluid shifts and potential cardiotoxicity associated with drugs like cyclophosphamide.
  • Pulmonary Function Testing (PFTs): These tests assess lung volume and gas exchange capacity. Patients with compromised lung function may require modified conditioning regimens to avoid respiratory failure.
  • Renal and Hepatic Assessment: Blood tests and 24-hour urine collections measure kidney filtration rates (GFR), while liver function tests screen for pre-existing damage or viral hepatitis. Since the liver and kidneys metabolize many transplant medications, baseline dysfunction requires careful dose adjustments.
  • Dental and Infectious Disease Screening: A thorough dental exam is required to identify and treat occult infections (like abscesses) that could become life-threatening during the period of immune suppression. Simultaneously, serology tests screen for past exposure to viruses like CMV, EBV, HIV, and Hepatitis, as these can reactivate post-transplant.

Donor Selection and HLA Typing

Diagnosis and Evaluation img 4 11 LIV Hospital

For allogeneic transplants, identifying a compatible donor is the most pivotal step. This process relies on Human Leukocyte Antigen (HLA) typing. HLAs are proteins found on the surface of most cells that help the immune system distinguish between “self” and “non-self.”

  • High-Resolution DNA Typing: This advanced genetic test compares the patient’s HLA markers with those of potential donors. The goal is to match at least 8-10 specific HLA alleles.
  • The Donor Hierarchy: The search typically begins with siblings, who have a 25% chance of being a perfect match. If no sibling is available, the search extends to international volunteer registries (Matched Unrelated Donor – MUD). If a fully matched unrelated donor cannot be found, clinicians evaluate alternative options, such as haploidentical (half-matched) family members or umbilical cord blood units.

Donor Health Screening: Once a donor is identified, they undergo their own medical evaluation to ensure they are healthy enough to donate and do not carry transmissible infections or genetic conditions.

Psychosocial and Caregiver Evaluation

Diagnosis and Evaluation img 5 9 LIV Hospital

A stem cell transplant is not just a physical challenge; it is a psychological marathon. The evaluation phase includes an assessment of the patient’s mental health, resilience, and social support network.

  • Caregiver Requirement: Most transplant centers require the patient to have a dedicated caregiver—a family member or friend—who can assist with medication management, transportation, and hygiene during the vulnerable post-transplant period.
  • Psychological Resilience: Coping mechanisms are evaluated to ensure the patient can handle the isolation and stress of a prolonged hospital stay. Support services are often integrated early to help patients navigate the emotional complexities of the procedure.

Fertility Preservation

Diagnosis and Evaluation img 6 9 LIV Hospital

The high-dose chemotherapy used in conditioning regimens carries a high risk of causing permanent infertility. As part of the pre-transplant evaluation, patients of reproductive age are counseled on fertility preservation options. For men, sperm banking is a standard and adequate precaution. For women, options may include egg or embryo freezing, depending on the urgency of the transplant and the patient’s medical stability. Addressing these quality-of-life issues is a crucial component of the holistic care model in regenerative medicine.

30
Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical expertise and hospitality to every individual who walks through our doors.  

Book a Free Certified Online Doctor Consultation

Doctors

Table of Contents

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

FREQUENTLY ASKED QUESTIONS

What is HLA typing, and why is it critical?

HLA (Human Leukocyte Antigen) typing is a genetic test used to match patients with donors. These antigens are markers on cells that the immune system uses to recognize which cells belong in the body. A close HLA match is critical to prevent the donor’s immune cells from attacking the patient’s body (graft-versus-host disease) and to prevent the patient’s body from rejecting the new stem cells.

Chemotherapy destroys white blood cells, leaving you unable to fight infections. A minor tooth infection or gum disease that is currently painless could flare up into a severe, life-threatening systemic infection (sepsis) when your immune system is compromised. Clearing dental issues beforehand removes this risk.

Minimal Residual Disease refers to the small number of cancer cells that may remain in the body after treatment, which cannot be seen under a microscope but can be detected by sensitive genetic tests. A negative MRD result means no cancer cells were found, which generally predicts a better outcome for the transplant.

Yes, in an autologous transplant, you act as your own donor. Your stem cells are collected and frozen before you receive high-dose chemotherapy. However, this is only an option for certain diseases (like myeloma or lymphoma) and requires that your bone marrow is relatively free of cancer cells and healthy enough to be harvested.

The timeline varies. If a sibling is a match, the process can move quickly, often within weeks. If an unrelated donor must be found through a registry, it can take several months to identify, contact, and test potential matches. In urgent cases, doctors may opt for a haploidentical (half-match) donor to proceed more rapidly.

Spine Hospital of Louisiana

Let's Talk About Your Health

BUT WAIT, THERE'S MORE...

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

Contact Us to Get Information!

Contact
Your Comparison List (you must select at least 2 packages)